Indiana Neurology and Pain Center LLC

Indiana Neurology and Pain Center LLC was paid $6.14M by Medicaid between Feb 2018 and Dec 2024, across 62 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,046	$22K
2019	5,557	$191K
2020	16,092	$630K
2021	20,955	$1.09M
2022	25,991	$1.29M
2023	35,238	$1.52M
2024incomplete	52,363	$1.39M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	23%	31,206	24,960	$1.44M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	13%	8,932	8,010	$779K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	9.5%	18,534	15,616	$581K
95913		7.7%	3,593	2,975	$474K
64635		6.8%	2,293	1,828	$415K
64636		5.3%	2,381	1,793	$323K
95886		5.2%	3,904	3,235	$322K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.1%	10,211	7,822	$313K
62323		4.3%	2,850	2,249	$265K
64493		3.7%	2,291	1,773	$225K
L0650	Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf	3.4%	362	309	$211K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.3%	2,095	1,745	$144K

50 more codes

27096		2.3%	2,000	$142K
64494		1.7%	2,427	$105K
77002		1.3%	1,764	$81K
62321		<1%	431	$49K
20610		<1%	1,505	$41K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,702	$40K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	9,935	$38K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	252	$19K
76942		<1%	745	$18K
64495		<1%	1,425	$16K
95912		<1%	134	$16K
64490		<1%	136	$15K
20552		<1%	764	$13K
80305		<1%	1,727	$10K
64491		<1%	140	$7K
99215	Doctor's office visit, returning patient (complex)	<1%	109	$7K
95887		<1%	140	$4K
20526		<1%	105	$3K
64633		<1%	16	$3K
64634		<1%	18	$3K
97162		<1%	47	$2K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	122	$2K
97161		<1%	34	$2K
72141		<1%	38	$2K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	113	$1K
64418		<1%	36	$1K
64492		<1%	57	$488.58
20611		<1%	30	$320.30
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	723	$311.19
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	3,737	$251.67
G9902	Patient screened for tobacco use and identified as a tobacco user	0%	3,364	$0.00
G8867	Pneumococcal vaccine not administered or previously received, reason not given	0%	4,469	$0.00
1123F		0%	1,026	$0.00
G8952	Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given	0%	1,301	$0.00
G9903	Patient screened for tobacco use and identified as a tobacco non-user	0%	4,046	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	24	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	2,391	$0.00
G8482	Influenza immunization administered or previously received	0%	4,863	$0.00
0518F		0%	1,132	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	2,280	$0.00
1124F		0%	6,610	$0.00
G8730	Pain assessment documented as positive using a standardized tool and a follow-up plan is documented	0%	1,330	$0.00
99490	Ccm add 20min	0%	183	$0.00
G9500	Radiation exposure indices documented in final report for procedure using fluoroscopy	0%	1,082	$0.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	0%	3,284	$0.00
G8864	Pneumococcal vaccine administered or previously received	0%	1,669	$0.00
G9584	Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy	0%	18	$0.00
M1316	Current tobacco non-user	0%	42	$0.00
G9276	Documentation that patient is a current tobacco user	0%	46	$0.00
G9562	Patients who had a follow-up evaluation conducted at least every three months during opioid therapy	0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKUNDI, SAMIULLAH (SOLE MEMBER)